Top Markets
Coin of the day
Abpro Corporation Abpro Corporation

Abpro Corporation

ABP
Classifica tra le azioni #39900
Abpro Holdings, Inc. is a biotechnology firm dedicated to creating... Abpro Holdings, Inc. is a biotechnology firm dedicated to creating antibody-based treatments for patients suffering from conditions in immuno-oncology, ophthalmology, and autoimmunity. A key element of their strategy is the proprietary DiversImmune platform, which aims to resolve a significant hurdle in the antibody therapeutics sector. Their primary investigational drug candidates include ABP-100, designed to target breast, gastric, and colorectal cancers, and ABP-201, intended for the treatment of vascular diseases affecting the eye. The company has established strategic alliances with Abpro Bio Co. Ltd and NJCTTQ. Originally known as Abpro Corporation, the company officially changed its name to Abpro Holdings, Inc. in November 2024. Incorporated in 2004, Abpro Holdings, Inc. operates from its headquarters in Woburn, Massachusetts.
Prezzo delle azioni
$0.158
Ultima sincronizzazione: 2026-04-06
Capitalizzazione di mercato
$302.92K
Variazione (1 giorno)
16.18%
Variazione (1 anno)
-97.91%
Paese
US
Scambia Abpro Corporation (ABP)

Categoria

Storico del rendimento da dividendi per Abpro Corporation (ABP)
Il rendimento da dividendi (TTM) di Abpro Corporation (simbolo azionario: ABP) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Abpro Corporation (ABP) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
0.00%
US
0.00%
NL
0.00%
CH
0.00%
KR
0.65%
BE